Showing posts with label Funding. Show all posts
Showing posts with label Funding. Show all posts

03 June 2026

Funding Quantum Hardware, Forsaking Research Talent: The Deepening Crisis in Australian Science

Image generated by Google Gemini based on author prompt.It has been just over two years since the Australian and Queensland governments announced their near-billion-dollar joint venture to fund PsiQuantum. Back in April 2024, policymakers excitedly pitched the construction of a utility-scale quantum computer at Brisbane Airport as an ‘anchor’ for the next industrial revolution. I did not write about it then.  Like many, I assumed the inevitable collision with technical and logistical reality would happen quietly, behind closed doors, perhaps eventually leading to a scaled-back scope or an extended timeline.

But here we are in mid-2026, and the wheels are visibly wobbling.  Last month, the much-touted Brisbane Airport site was unceremoniously abandoned in favour of a council-owned site at Moreton Bay Central.  Yet, despite pivoting to an empty lot at a former paper mill, it appears that neither the company nor the government has publicly walked back their foundational commitment to have the site operational by the end of 2027.  Promising to build the world's first million-qubit, fault-tolerant computer from the ground up in just 18 months is, to put it mildly, an ambitious logistical – and technical –  undertaking!

More importantly, I am writing about this now because we should not continue to ignore the sheer opportunity cost of this mega-project.  While the government plays venture capitalist with a single, highly speculative hardware gamble, the reality is that Australian science may be reaching a breaking point.

According to the Australian Bureau of Statistics (ABS), Australia’s Gross Expenditure on R&D (GERD) was a mere 1.69% of GDP in 2023-24.  This leaves us languishing far behind the OECD average, estimated at 2.93% in 2023, and significantly outpaced by peer economies that treat foundational research as critical infrastructure rather than a discretionary expense.

We are, quite literally, starving the ecosystem.

There is a profound irony at the heart of the PsiQuantum deal.  The company is headquartered in Silicon Valley, but its co-founders are products of the Australian university system.  They are the quintessential example of the ‘brain drain’ – talented innovators who left Australia when the domestic funding ecosystem failed to support their ambition.  This leaves us spending nearly a billion dollars of taxpayer money to effectively buy back our own exported talent at a massive premium.

Yet, in doing so, we are contributing to the collapse of the very STEM pipeline required to produce the next generation of innovators.  How does a government justify a near-billion-dollar bet on a speculative hardware project while simultaneously starving the foundation?  The answer, as is so often the case in technology policy, lies in a deliberate semantic conflation.  By using the word ‘quantum’ as a monolithic buzzword, policymakers have successfully blurred the lines between practical, deployable technologies and a long-term engineering marathon.

Let's dive in and look at the data.

07 December 2011

Australian Government Improves Access to Commercialisation Grants

GrantedThe Australian Minister for Innovation, Industry, Science and Research, Senator Kim Carr, has announced changes to the governments Commercialisation Australia program which will make the grants more affordable and accessible to Australian businesses developing new products, processes or services.

From today (7 December 2011) Australian entrepreneurs will not have to repay the program’s Early Stage Commercialisation grants.  Additionally, these grants will be available to more businesses, with the maximum annual turnover permitted by eligible applicants has risen from $20 million to $50 million.

In addition, growing businesses that can benefit from access to skilled managers will now be able to apply for an Experienced Executives grant of up to $350,000, increased from $200,000.

Announcing these changes to Commercialisation Australia's grants, Senator Carr said that they would give Australian inventions a better chance of flourishing in the market place.

Further changes appear to be in the air, with the Minister also announcing that, from early 2012, eligible expenditure guidelines for Early Stage Commercialisation grants will be amended to provide broader support for the development of pilot manufacturing plants and innovative manufacturing facilities.

16 June 2011

Australian R&D Tax Credit to Commence on 1 July 2011

On 15 June 2011, the Australian Minister for Innovation, Industry, Science and Research, Senator Kim Carr, Jointly with the Treasurer Wayne Swan, announced that crossbench Senators are giving their support to a new R&D Tax Credit Program.

The R&D Tax Credit was announced in the May 2009 Budget as part of the Government’s Innovation Agenda, Powering Ideas – An Innovative Agenda for the 21st Century.  It was originally intended to commence on 1 July 2010, but has been delayed for a year due to what the Labor Government has characterised as a ‘parliamentary road-block put in place by the [Liberal/National conservative] Coalition’. 

As of July, the new Senators elected in last year’s elections take their seats, resulting in a major change in the make-up of the upper house, with nine Greens senators gaining the balance of power.

Although the final legislation will not be passed until after 1 July 2011, when the new Senate sits, companies undertaking eligible R&D activities from this date will be entitled to access the R&D Tax Credit.

20 April 2011

Update on Campaign Against Medical Research Funding Cuts

Last week we reported on the ‘rumours’ (i.e ‘leaks’) suggesting that the Australian government is considering slashing a potential $400 million ($133 million annually, or around 19%) from the funding provided via the National Health and Medical Research Council (NHMRC), which currently distributes around $700 million each year to university, and other public sector, researchers.

As also reported, a campaign organised under the banner Discoveries Need Dollars has conducted rallies over the past week in every mainland State and Territory capital city, which have so far been attended by over 12,000 people.  The simultaneous Twitter campaign caused #protectresearch to trend not only in Australia, but also in the US and Canada.

In Tuesday 19 April 2011, Discoveries Need Dollars representatives met with senior members of the Federal Government in Canberra.

12 April 2011

Budget Cuts Threaten Australian Medical Research Funding

It is ‘budget season’ once again here in Australia – the time of year when government ‘sources’ start to leak like sieves with information regarding proposed measures in the (supposedly) confidential annual accounting to be announced by the Treasurer in May.

This year, we are greatly concerned by reports that the Australian government is considering slashing the budget for medical research funding by nearly 20%.  This is a disturbing and short-sighted proposal when the Australian economy remains strong, relative to our major trading partners, and medical research is one of the nation’s great strengths.  Australian contributions to medical research and innovation include antibiotics (Howard Florey), the use of lithium to treat psychiatric disorders (John Cade), the ‘bionic ear’ (Graeme Clark) and the cervical cancer vaccine (Ian Frazer), amongst many others.

Why, then, would the nation put this great legacy at risk to achieve short-term political gains?  If you find this as unacceptable as we do, please read on to learn more, and to find out how you can contribute to the various campaigns opposing the proposed cuts.

Copyright © 2014
Creative Commons License
The Patentology Blog by Dr Mark A Summerfield is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Australia License.